16/09/2026
H.C. Wainwright 28th Annual Global Investment Conference
10/03/2026
DNB Carnegie Nordic Healthcare Conference
25/02/2026
ABG Investor Presentation
25/11/2025
DNB Carnegie Nordic Healthcare Conference
10/09/2025
H.C. Wainwright Global Investment Conference
27/08/2025
Strategy Update & Q2 2025 Results Presentation
08/11/2024
Nykode Therapeutics VB10.NEO update – presentation
10/01/2024
42nd Annual J.P. Morgan Healthcare Conference, January 10, 2024 – presentation
14/12/2023
DNB Nordic Healthcare Conference, December 14, 2023 – presentation
17/11/2023
Jefferies Healthcare Conference, November 16, 2023 – presentation
27/09/2023
Nykode Therapeutics – Capital Markets Day in Oslo on September 27, 2023 – presentation
20/09/2023
Nykode Therapeutics – Capital Markets Day in New York on September 20, 2023 – presentation
11/09/2023
H.C. Wainwright 25th Annual Global Investment Conference, September 11, 2023 – presentation
07/06/2023
Jefferies Healthcare Conference, June 7, 2023 – presentation
07/06/2023
ABGSC Life Science Summit 30-31 May 2023 – presentation
19/04/2023
Nykode Therapeutics – Final Results from the Phase 2 VB-C-02 trial – presentation
18/04/2023
Nykode Therapeutics announces positive final results from its Phase 2 trial of VB10.16 in combination with PD-L1 inhibitor atezolizumab in advanced cervical cancer – presentation
09/01/2023
Nykode Therapeutics – Presentation at the 41st Annual J.P. Morgan Healthcare Conference
20/12/2022
Nykode Therapeutics – Clinical development plan for VB10.16 – presentation
24/11/2022
ABG oncology seminar, November 23, 2022 – presentation
07/11/2022
Credit Suisse 31st Annual Healthcare conference, 2022 – presentation
26/10/2022
Nykode Therapeutics Announces Presentation of Positive Immunogenicity Results from Phase 1/2a Study of VB10.NEO, an Individualized Therapeutic Cancer Vaccine, at the Neoantigen-Based Therapies Summit
27/09/2022
Initial Results from the Phase 1/2 Trial of the T Cell SARS-CoV-2 Vaccine Candidate VB10.2210 – presentation
13/09/2022
H.C. Wainwright 24th Annual Global Investment Conference, September 13, 2022 – presentation
08/06/2022
Jefferies Healthcare Conference, June 8-10, 2022 – presentation
12/05/2022
Capital Markets Day in Oslo on May 12, 2022 – presentation
09/05/2022
Nykode Therapeutics – Interim results from Phase 2 trial with VB10.16 in combination with atezolizumab in advanced cervical cancer – presentation
20/04/2022
Kempen Life Sciences Conference – April 20, 2021
01/04/2022
Nykode Therapeutics – full year 2021 financial results and corporate presentation
17/02/2022
SVB Leerink 2022 Global Healthcare Conference – February 18, 2022
19/01/2022
SEB Nordic Healthcare Seminar
05/01/2022
Company update on T cell focused COVID-19 vaccine candidate
23/11/2021
ABGSC Oncology Seminar
23/11/2021
Nykode Therapeutics company update
13/11/2019
VACCIBODY PRESENTATION, CAPITAL MARKETS DAY – OSLO, 12 NOVEMBER 2019
03/04/2019
COMPANY PRESENTATION – 13 FEBRUARY 2019
03/04/2019
LUNCH MEETING ARCTIC SECURITIES – 10 OCTOBER 2018
13/02/2019
COMPANY PRESENTATION – February 2019
